Personal payments from pharmaceutical companies to authors of clinical practice guidelines in oncology – Mitchell – – The Oncologist

The oncologist 2021; 26: 771-778; first published on May 26, 2021; doi: 10.1002 / onco.13823

Due to an editing error when compiling the authors’ financial information, errors have been introduced in the Disclosures section of this article. This error affected the published disclosures for Aaron P. Mitchell (which were incorrectly displayed) and Akriti Mishra (which were missing). The Disclosures section has been corrected in the online post and is displayed correctly in its entirety here.


Aaron P. Mitchell: Merck (RF [receipt of a research abstract award from the Conquer Cancer Foundation, which was partially funded by Merck]); Akriti Mishra: Johnson & Johnson, Teladoc (OI); Aaron N. Winn: Takeda (C / A); Stacie Dusetzina: Commonwealth Fund, Leukemia & Lymphoma Society, Arnold Ventures (RF), West Health, Institute for Clinical and Economic Review, National Academy of State Health Policy (C / A); Peter B. Bach: Kaiser Permanente, Laura and John Arnold Foundation (RF), American Society for Health-System Pharmacists, WebMD, Defined Health, JMP Securities, Mercer, United Rheumatology, Foundation Medicine, Grail, Morgan Stanley, NYS Rheumatology Society, Oppenheimer & Co., Cello Health, Oncology Analytics, Anthem, Magellan Health, Kaiser Permanente Institute for Health Policy, Congressional Budget Office, America’s Health Insurance Plans, Geisinger, EQRx, Meyer Cancer Center of Weill Cornell Medicine, National Pharmaceutical Council (C / A), Grail, Oncology analysis, EQRx (OI). The other authors did not indicate any financial relationship.

(C / A) Counseling / counseling relationship; (RF) Research funding; (E) Employment; (ET) Expert testimony; (H) Fees received; (OI) Property interests; (IP) Intellectual property rights / inventor / patent holder; (SAB) Scientific Council

About Terry Gongora

Check Also

A total of 790 million yen for the development of products against neglected tropical diseases

TOKYO, November 10, 2022 /PRNewswire/ — The Global Health Innovative Technology (GHIT) fund today announced …

Leave a Reply

Your email address will not be published.